Browse through out most popular and highest rated webinars to discover a wealth of information to help you manage the pharmacy benefit.
PBMI would like to thank Takeda Pharmaceuticals U.S.A., Inc. for sponsoring this report and webinar.
There has never been a period of greater change and uncertainty in pharmacy benefits – and the stakes for plan sponsors have never been higher. Biologics are the fastest growing segment of the pharmaceutical industry, and as patent protection expires for these high-cost drugs, a new market is opening up for biosimilars. Biosimilars will enter the market soon with the potential to provide savings of 10%-50% over biologics. This webcast covers the financial, legislative, and clinical aspects of biosimilar products in the U.S. market and gives you the innovative strategies you need to take control of soaring pharmacy costs.
Dr. Begley discusses barriers to specialty adherence, new data focusing on specialty only compliance, and new tools and vendor programs to engage members that have the highest cost to payers.
Hear results from PBMI's 2017 PBM Customer Satisfaction Report
Timothy Teen, President, Broadreach Medical Resources, Inc.
Elliot Berkovitz, PharmD, Director of Clinical Services, Broadreach Medical Resources, Inc.
Kaliopi Panagos, PharmD, RPh, Director of Clinical Operations, Broadreach Medical Resources, Inc.
Mike's primary focus is on strengthening the Employers Health brand and growing membership, particularly in the coalition's 20 year, $1 billion group purchasing program for pharmacy benefits.
Hear results from PBMI's 2017 Trends in Specialty Drug Benefit Report. Gain insight into the latest on:
PBMI would like to thank Walgreens for sponsoring this report and webinar.
Hear Dr. Craig Stern, President, Pro Pharma Pharmaceutical Consultants, and Dr. Matthew Lee, Health Plan of San Mateo, share insights to help the audience:
During this webinar, attendees will learn about current and pending legislation and various special interest influences that impact the development of laws and rules affecting the workers' compensation system. This insight will demonstrate what the various changes mean for the industry and how industry stakeholders can affect political change to their advantage.
The same drug can deliver an additional five months of life for lung cancer patients but only 12 days of life for pancreatic cancer patients. And there are certain specialty therapies to which many patients don't respond at all. Yet, plan sponsors have paid the same amount for medications like these regardless of the value they provide an individual patient. That is all beginning to change as the industry experiments in ways that better correlate a drug's price to the value it delivers for the patient.
Hear Adam Kautzner discuss this industry trend, and specifically explain a novel value-driven approach - a combination of indication-based reimbursement capabilities, PBM risk-sharing, and an integrated "whole patient" approach to specialty pharmacy - to improve the cost and care of medications that treat both cancer and inflammatory conditions.
During this webinar, Dr. Kristin Begley will discuss and explain strategies to increase adherence as well as share published research to support the efficacy of these strategies. She will focus on direct ideas a plan sponsor can put in place to move the needle on adherence and make the pharmacy benefit more effective at controlling overall costs.
Hear how two plans, Duke and Manatee, worked with their PBM to place a dedicated pharmacist in their office to manage their overall pharmacy benefit.
During this webinar, Keith Bruhnsen, University of Michigan Drug Plan, and Libby Johnson, PSG Consulting, will highlight unique strategies implemented by the plan to manage their growing drug trend. It will include market information and plan results for managing pharmacy drug trend in an ever-evolving marketplace.